February 27, 2018 / 4:41 PM / 3 months ago

BRIEF-Valbiotis Completes Phase I/II Clinical Study Recruitment For VAL-070

Feb 27 (Reuters) - VALBIOTIS SAS:

* VALBIOTIS COMPLETES PHASE I/II CLINICAL STUDY RECRUITMENT FOR VAL-070, A PRODUCT TO REDUCE A CARDIOVASCULAR RISK FACTOR

* ‍CLINICAL SAFETY AND EFFICACY RESULTS ARE EXPECTED FOR MID-2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below